SCL vs ZBH · P/E 22, rev $2.18B vs P/E 23, rev $7.68B
Stepan Company (SCL) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Stepan Company (SCL) is a specialty chemicals company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported SCL revenue for 2024-12-31 was $2.18B. Net income was $50.4M. Revenue was down 6.3% from 2023-12-31 to 2024-12-31. SCL currently screens at market cap $1.29B and trailing P/E 22.3.
Latest reported ZBH revenue for 2024-12-31 was $7.68B. Net income was $905.3M. Revenue was up 3.8% from 2023-12-31 to 2024-12-31. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
SCL currently screens at market cap $1.29B and trailing P/E 22.3. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the SCL and ZBH stock pages for the full models.
Not investment advice.